1. Home
  2. CTMX vs PRPL Comparison

CTMX vs PRPL Comparison

Compare CTMX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • PRPL
  • Stock Information
  • Founded
  • CTMX 2008
  • PRPL 2010
  • Country
  • CTMX United States
  • PRPL United States
  • Employees
  • CTMX N/A
  • PRPL N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • CTMX Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • CTMX 444.3M
  • PRPL 78.9M
  • IPO Year
  • CTMX 2015
  • PRPL N/A
  • Fundamental
  • Price
  • CTMX $2.39
  • PRPL $0.70
  • Analyst Decision
  • CTMX Strong Buy
  • PRPL Hold
  • Analyst Count
  • CTMX 2
  • PRPL 2
  • Target Price
  • CTMX $5.00
  • PRPL $1.25
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • PRPL 716.8K
  • Earning Date
  • CTMX 08-07-2025
  • PRPL 08-04-2025
  • Dividend Yield
  • CTMX N/A
  • PRPL N/A
  • EPS Growth
  • CTMX 128.27
  • PRPL N/A
  • EPS
  • CTMX 0.49
  • PRPL N/A
  • Revenue
  • CTMX $147,557,000.00
  • PRPL $472,015,000.00
  • Revenue This Year
  • CTMX N/A
  • PRPL N/A
  • Revenue Next Year
  • CTMX N/A
  • PRPL $10.65
  • P/E Ratio
  • CTMX $4.91
  • PRPL N/A
  • Revenue Growth
  • CTMX 23.81
  • PRPL N/A
  • 52 Week Low
  • CTMX $0.40
  • PRPL $0.56
  • 52 Week High
  • CTMX $3.10
  • PRPL $1.50
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 51.66
  • PRPL 41.83
  • Support Level
  • CTMX $2.33
  • PRPL $0.70
  • Resistance Level
  • CTMX $2.79
  • PRPL $0.74
  • Average True Range (ATR)
  • CTMX 0.17
  • PRPL 0.04
  • MACD
  • CTMX -0.01
  • PRPL -0.00
  • Stochastic Oscillator
  • CTMX 42.03
  • PRPL 0.50

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

Share on Social Networks: